about
GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI B...
Read More
2.45
0.09
(3.81%)
227.5K
XNAS Volume
High vol. this week
XNAS 10 Apr, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
GRI Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..